Cutera, Inc. (NASDAQ:CUTR – Get Free Report) saw a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 4,400,000 shares, an increase of 8.9% from the November 15th total of 4,040,000 shares. Based on an average daily trading volume, of 290,700 shares, the short-interest ratio is presently 15.1 days.
Cutera Stock Performance
NASDAQ:CUTR opened at $0.35 on Tuesday. Cutera has a 12 month low of $0.28 and a 12 month high of $4.97. The firm’s 50 day moving average is $0.51 and its 200 day moving average is $0.96. The stock has a market capitalization of $7.15 million, a PE ratio of -0.05 and a beta of 1.26.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in the stock. Ground Swell Capital LLC bought a new stake in Cutera during the second quarter worth about $37,000. Bank of Montreal Can boosted its holdings in Cutera by 14.2% during the 2nd quarter. Bank of Montreal Can now owns 282,704 shares of the medical device company’s stock valued at $455,000 after acquiring an additional 35,248 shares during the period. Finally, Squarepoint Ops LLC grew its position in Cutera by 164.5% during the 2nd quarter. Squarepoint Ops LLC now owns 113,964 shares of the medical device company’s stock worth $172,000 after acquiring an additional 70,870 shares during the last quarter. Institutional investors own 90.70% of the company’s stock.
Analysts Set New Price Targets
View Our Latest Stock Analysis on CUTR
Cutera Company Profile
Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.
Read More
- Five stocks we like better than Cutera
- What Does a Stock Split Mean?
- HCA Healthcare: 4 Reasons to Buy the 25% Dip
- Dividend Capture Strategy: What You Need to Know
- 3 Dividend Leaders Set for Strong Growth in 2025
- What Are Dividend Achievers? An Introduction
- 3 Stocks to Gain From Stockpiling Effects of the Trump Tariffs
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.